Evidence map›Paper›PMID 42152189›Full record

ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2026

Examining the relevance of gait speed resiliencies to different stressors: the ARIC Study.

B Gwen Windham, Hunter C Sylvester, James Henegan, Matthew McMullan, Anna Kucharska-Newton, Priya Palta, Jennifer A Schrack, Thomas H Mosley, Karen Bandeen-Roche, Michael E Griswold

Abstract read
In one paragraph

Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

B Gwen WindhamThe Memory Impairment and Neurodegenerative Dementia (MIND) Center, The University of Mississippi Medical Center, Jackson, Mississippi, United States.ORCID 0000-0001-6240-5044
Hunter C SylvesterThe Memory Impairment and Neurodegenerative Dementia (MIND) Center, The University of Mississippi Medical Center, Jackson, Mississippi, United States.
James HeneganThe Memory Impairment and Neurodegenerative Dementia (MIND) Center, The University of Mississippi Medical Center, Jackson, Mississippi, United States.
Matthew McMullanThe Memory Impairment and Neurodegenerative Dementia (MIND) Center, The University of Mississippi Medical Center, Jackson, Mississippi, United States.
Anna Kucharska-NewtonDepartment of Epidemiology, University of North Carolina Chapel Hill, Chapel Hill, North Carolina, United States.ORCID 0000-0001-9864-467X
Priya PaltaDepartment of Neurology, University of North Carolina Chapel Hill, Chapel Hill, North Carolina, United States.
Jennifer A SchrackDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States.ORCID 0000-0001-9244-9267
Thomas H MosleyThe Memory Impairment and Neurodegenerative Dementia (MIND) Center, The University of Mississippi Medical Center, Jackson, Mississippi, United States.
Karen Bandeen-RocheDepartment of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States.
Michael E GriswoldThe Memory Impairment and Neurodegenerative Dementia (MIND) Center, The University of Mississippi Medical Center, Jackson, Mississippi, United States.ORCID 0000-0001-8106-5516

Funding

ARIC Neurocognitive Study (ARIC-NCS) Renewal 2023-2028U01HL096812 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI JOSEF CORESH, THOMAS H MOSLEY · 2010 to 2026
$65.7M
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - COORDINATING CENTER - TASK AREA B.2 AND B.375N92022D00001 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COUPER, DAVID · 2022 to 2025
$13.7M
ARIC Neurocognitive Study (ARIC-NCS) Renewal 2 of 5U01HL096917 · NHLBI · UNIVERSITY OF MISSISSIPPI MED CTR · PI MOSLEY, THOMAS H · 2010 to 2018
$11.9M
ARIC Neurocognitive Study (ARIC-NCS) Renewal UNC 4 of 5U01HL096899 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COUPER, DAVID J · 2010 to 2018
$7.5M
ARIC Neurocognitive Study (ARIC-NCS)U01HL096902 · NHLBI · UNIVERSITY OF MINNESOTA · PI LUTSEY, PAMELA L. · 2010 to 2018
$7.4M
ARIC Neurocognitive Study (ARIC-NCS) Renewal 4 of 5U01HL096814 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HUGHES, TIMOTHY M., WAGENKNECHT, LYNNE E · 2010 to 2018
$6.5M
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A75N92022D00003 · NHLBI · UNIVERSITY OF MINNESOTA · PI LUTSEY, PAMELA L. · 2022 to 2025
$5.1M
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A75N92022D00005 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI WAGENKNECHT, LYNNE E · 2022 to 2025
$5.0M
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A75N92022D00004 · NHLBI · UNIVERSITY OF MISSISSIPPI MED CTR · PI WINDHAM, BEVERLY GWEN · 2022 to 2025
$4.8M
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A75N92022D00002 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI ARGANI, PEDRAM · 2022 to 2025
$4.7M
HHS 75N92022D00001HHS 75N92022D00002HHS 75N92022D00003HHS 75N92022D00004HHS 75N92022D00005National Heart, Lung, and Blood Institute, National Institutes of HealthNational Institutes of Health (National Heart, Lung, and Blood Institute, National Institute of Neurological Disorders and Stroke, National Institute on Aging, and National Institute on Deafness and Other Communication Disorders)NHLBI NIH HHS 75N92022D00001NHLBI NIH HHS 75N92022D00002NHLBI NIH HHS 75N92022D00003NHLBI NIH HHS 75N92022D00004NHLBI NIH HHS 75N92022D00005NHLBI NIH HHS U01 HL096812NHLBI NIH HHS U01 HL096814NHLBI NIH HHS U01 HL096899NHLBI NIH HHS U01 HL096902NHLBI NIH HHS U01 HL096917The ARIC Neurocognitive U01HL096812The ARIC Neurocognitive U01HL096814The ARIC Neurocognitive U01HL096899The ARIC Neurocognitive U01HL096902The ARIC Neurocognitive U01HL096917
6 · The paper itself

Abstract

backgroundDifferent stressors may impact physical resilience differently (resiliencies). Objective metrics assessing different stressors' "relevance" on associated resiliencies are lacking. We propose an approach for defining relevance metrics and potential moderating effects of sex and mortality on gait speed resiliencies.

methodsAmong 1559 ARIC participants (age 66-80 years) with "good" gait speed (≥1 m/s), 864 (55%) maintained good gait speed at follow-up (mean 6.5 years). Gait speed resiliencies were defined using 11 intermediary stressors (stroke, cancer, depression, etc.). Each stressor's relevance was examined using Relative Ratios (RRs, 95% CI), comparing the prevalence of maintaining good gait speed among those experiencing the stressor (resilience) against the prevalence among those without the stressor, adjusting for demographics and body mass index. Mortality effects and sex differences were examined.

resultsStressor relevance varied from greatest (self-reported poor health: RR = 0.41, [95% CI, 0.26, 0.65], 59% reduction in maintaining good gait speed), to least influential (poor social support RR = 1.02 [0.89, 1.18]), with 6/11 stressors supported as relevant. Mortality and sex-differences were present; an intermediary fall was more relevant for women, where maintaining good speed versus dying was 76% less likely after a fall, RRWomen = 0.24 (0.12, 0.50), compared to men, RRMen = 0.75 (0.39, 1.44), yielding a 67% lower chance of women having good speed versus dying after a fall than men, relevance RR-ratio = (RRWomen/RRMen) = 0.33 (0.12, 0.86).

conclusionsStudies of physical resilience should use objective metrics to examine the relevance/importance of different combinations of stressors and functional outcomes when defining physical resiliencies. The relevance of gait speed resiliencies can vary by stressors, mortality inclusion in resiliencies, and sex.

Indexed as

Stress, PsychologicalWalking SpeedAgedAged, 80 and overFemaleHumansMaleSex FactorsEpidemiologyGaitPhysical performanceResilience

Identifiers

PMID42152189
PMCPMC13403272

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.